Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
RVNC holding history
Revance Therapeutics, Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RVNC overviewAll 13F holders of RVNCFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −1,328,525−100.0% | Sold out | Holders |
| Q4 2024 | 1,328,525 | $4.04M | <0.1% | −562,736−29.8% | Reduced | Holders |
| Q3 2024 | 1,891,261 | $9.82M | <0.1% | +1,891,261 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −503,874−100.0% | Sold out | Holders |
| Q4 2023 | 503,874 | $4.43M | <0.1% | +389,624+341.0% | Added | Holders |
| Q3 2023 | 114,250 | $1.31M | <0.1% | −24,347−17.6% | Reduced | Holders |
| Q2 2023 | 138,597 | $3.51M | <0.1% | +85,576+161.4% | Added | Holders |
| Q1 2023 | 53,021 | $1.71M | <0.1% | −88,859−62.6% | Reduced | Holders |
| Q4 2022 | 141,880 | $2.62M | <0.1% | +113,211+394.9% | Added | Holders |
| Q3 2022 | 28,669 | $774.0K | <0.1% | +28,669 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −23,435−100.0% | Sold out | Holders |
| Q2 2021 | 23,435 | $695.0K | <0.1% | +23,435 | New | Holders |